Strides Pharma Science arm gets USFDA nod for drug to treat overactive bladder
The approved product is a generic version of Vesicare tablets of Astellas Pharma US, Inc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 26, 2019 Category: Pharmaceuticals Source Type: news
Axonics Takes on Medtronic in Sacral Neuromodulation for Bowel and Bladder Control
This article really demonstrated and did a very nice job in separating out the different types of anticholinergic medications and, specifically, the anticholinergic medications to treat overactive bladder, which is the primary pharmacological intervention that we have," Noblett said.
The researchers analyzed the data by type of burden and level of burden (low, medium, high) and found that the risk of dementia, even in the low burden, went up by 19% and in the high burden was up by 60%.Â
"And those were just for patients with the overactive bladder anticholinergic," Noblett sa...
Source: MDDI - September 4, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Gait speed and overactive bladder in the healthy community-dwelling super elderly: the Sukagawa Study - Omae K, Yamamoto Y, Kurita N, Takeshima T, Naganuma T, Takahashi S, Ohnishi T, Ito F, Yoshioka T, Fukuhara S.
The objective of this study is to assess the association of muscle mass, grip strength, and gait speed with overactive bladder (OAB) in community-dwelling elderly adults. METHODS: This cross-sectional study was based on the data collected from... (Source: SafetyLit)
Source: SafetyLit - August 26, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
FemPulse Enrolls 1st Patient in Feasibility Study for OAB in Women
FemPulse is looking to make an impact in the bioelectronic medicine market with therapy for the personalized treatment of overactive bladder (OAB) in women.  The Minneapolis-based company said the first participant had been enrolled in a feasibility study evaluating physiological responses to therapy delivered with the FemPulse System.
Observations from this feasibility study can further help elucidate the mechanisms of action and facilitate tailoring treatment plans for individual patients. The clinical trial is an open-label, single-group assignment. Participants will wear a FemPulse ...
Source: MDDI - July 15, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Electronics Source Type: news
Medical News Today: These common drugs may increase dementia risk
Drugs that doctors often use in the treatment of overactive bladder, gastrointestinal conditions, and depression may increase dementia risk by almost half. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 25, 2019 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news
These common drugs may increase dementia risk
Drugs that doctors often use in the treatment of overactive bladder, gastrointestinal conditions, and depression may increase dementia risk by almost half. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 25, 2019 Category: Neurology Tags: Alzheimer's / Dementia Source Type: news
Alembic Pharma gets USFDA nod for overactive bladder treatment drug
The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the strengths of 5 mg and 10 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 20, 2019 Category: Pharmaceuticals Source Type: news
Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study - Szabo SM, Gooch K, Schermer C, Walker D, Lozano-Ortega G, Rogula B, Deighton A, Vonesh E, Campbell N.
OBJECTIVE: To estimate the association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder (OAB). DESIGN: A retrospective claims-based study (2007-2015) of patients with OAB; outcomes from a subset ... (Source: SafetyLit)
Source: SafetyLit - May 9, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Re: the association between overactive bladder and falls and fractures: a systematic review - Wein AJ.
[Abstract unavailable]
Language: en... (Source: SafetyLit)
Source: SafetyLit - April 29, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Finally, a Wearable Neuromodulation Device for Overactive Bladder
As a urogynecology surgeon, Alexandra Haessler, MD, has seen firsthand the limitations of current overactive bladder (OAB) therapies.
Aside from medication, the current gold standard for OAB is Medtronic's InterStim, an implantable sacral neuromodulation device that is FDA approved for the treatment of OAB as well as chronic fecal incontinence, and non-obstructive urinary retention.
Haessler told MD+DI that the InterStim device works very well but it's an expensive treatment and access is limited because only a few subspecialists in any one metropolitan area are truly qualified to deliver the therapy. The InterStim is not ...
Source: MDDI - April 19, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Zydus Cadila gets tentative USFDA nod for overactive bladder treatment drug
The product will be manufactured at the group's manufacturing facility at SEZ in Ahmedabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 1, 2019 Category: Pharmaceuticals Source Type: news
Even younger nightshift workers shown to need to pee more, worsening quality of life
(European Association of Urology) Millions of people work nights, but increasingly scientists are finding that night work is associated with health problems. Now a group of Italian scientists has found that nightshift workers also need to pee more, leading to a deteriorating quality of life for many workers, including care workers. This is also true of younger subjects, who would not normally be expected to report an overactive bladder. This work is reported at the European Association of Urology Congress in Barcelona. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 15, 2019 Category: International Medicine & Public Health Source Type: news
Bioness StimRouter(R) Neuromodulation System Receives European CE Mark Approval for the Treatment of Overactive Bladder (OAB)
FDA-Approved StimRouter Continues to Improve the Lives of Chronic Pain Patients in the United States
VALENCIA, Calif., Feb. 19, 2019 -- (Healthcare Sales & Marketing Network) -- Bioness, Inc., the leading provider of state-of-the-art, clinically suppor... Devices, Neurology, Urology, Regulatory Bioness, StimRouter, Neuromodulation, Overactive Bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 19, 2019 Category: Pharmaceuticals Source Type: news
A Novel Tibial Nerve Stimulation Device for OAB A Novel Tibial Nerve Stimulation Device for OAB
Could this ambulatory transcutaneous tibial nerve stimulation device be an effective treatment option for patients with overactive bladder?Translational Andrology and Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 25, 2019 Category: Consumer Health News Tags: Urology Journal Article Source Type: news
Light-up 'belt' that shines on the bladder could stop embarrassing leaks
The surgically implanted device is designed to combat overactive bladder — which affects around eight million people in Britain. (Source: the Mail online | Health)
Source: the Mail online | Health - January 21, 2019 Category: Consumer Health News Source Type: news
